Label: CLARISONIC PORE AND BLEMISH CLEANSER ACNE TREATMENT- salicylic acid gel

  • NDC Code(s): 69481-333-01
  • Packager: Pacific Bioscience Laboratories, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 27, 2023

If you are a consumer or patient please visit this version.

  • Active ingredient

    Salicylic acid 2%

  • Purpose

    Acne treatment

  • Uses

    for the treatment of acne

  • Warnings

    For external use only

  • When using this product

    skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • apply directly to moistened skin or to a damp Clarisonic skin cleansing brush
    • massage onto face, avoiding the eye area
    • rinse thoroughly
  • Inactive ingredients

    water, sodium laureth sulfate, decyl glucoside, glycerin, sodium chloride, coco-betaine, PEG-150 pentaerythrityl tetrastearate, PEG-6 caprylic/capric glycerides, zinc gluconate, sodium hydroxide, sodium benzoate, tetrasodium EDTA, capryloyl salicylic acid, citric acid, menthol, hexylene glycol, polyquaternium-47

  • Questions?

    Call 1-888-525-2747

  • PRINCIPAL DISPLAY PANEL

    image of a carton

    image of a carton
  • INGREDIENTS AND APPEARANCE
    CLARISONIC PORE AND BLEMISH CLEANSER ACNE TREATMENT 
    salicylic acid gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69481-333
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    SODIUM LAURETH SULFATE (UNII: BPV390UAP0)  
    DECYL GLUCOSIDE (UNII: Z17H97EA6Y)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    COCO-BETAINE (UNII: 03DH2IZ3FY)  
    PEG-150 PENTAERYTHRITYL TETRASTEARATE (UNII: 8L4OOQ76AM)  
    PEG-6 CAPRYLIC/CAPRIC GLYCERIDES (UNII: GO50W2HWO8)  
    ZINC GLUCONATE (UNII: U6WSN5SQ1Z)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    EDETATE SODIUM (UNII: MP1J8420LU)  
    CAPRYLOYL SALICYLIC ACID (UNII: 5F7PJF6AA4)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    MENTHOL (UNII: L7T10EIP3A)  
    HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
    POLYQUATERNIUM-47 (METHACRYLAMIDOPROPYLTRIMETHYLAMMONIUM CHLORIDE-CO-METHYL ACRYLATE-CO-ACRYLIC ACID 45:10:45; 1200000 MW) (UNII: F11YNO8FDQ)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69481-333-01120 mL in 1 TUBE; Type 0: Not a Combination Product08/10/201706/10/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00608/10/201706/10/2024
    Labeler - Pacific Bioscience Laboratories, Inc. (024874849)
    Establishment
    NameAddressID/FEIBusiness Operations
    L'Oreal USA, Inc.185931458manufacture(69481-333) , pack(69481-333)